Clinical Application of MicroRNA in Exosomes as Biomarkers for the Diagnosis of Liver Cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000036667

Enrollment

Unknown

Registered

2020-08-24

Start date

2020-09-01

Completion date

Unknown

Last updated

2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Interventions

Gold Standard:Pathological diagnosis

Index test:microRNAs

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed as hepatocellular carcinoma and received tumor resection in our hospital from December 10th 2019 to December 10th 2029 with complete information.

Exclusion criteria

Exclusion criteria: 1. Patients were less than 18 years old; 2. Patients with serious cardiovascular,lung,kidney,immune and hematological diseases and cerebrovascular disease; 3. Patients with severe acute inflammation and mental illness; 4. Patients who refused to consent to this study.

Design outcomes

Primary

Measure	Time frame
microRNA;SEN, SPE, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactLu Minqiang

Department of HBP Surgery II, Guangzhou First People's Hospital, School of Medicine, South China University of Technology

larrylmq@outlook.com+86 13802747201

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026